Armor Study News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Armor Study. Real-time updates on events, politics, business and more.

Galmed Pharmaceuticals Reports First Quarter 2022 Financial Results

May 17, 2022

/PRNewswire/ —Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic, fibrosis...

Hebrew University Galmed Pharmaceuticals Ltd Galmed Pharmaceuticals Open Label Part Armor Study First Quarter

Source: prnewswire.com

Galmed updates business and clinical development strategy to better leverage Aramchol's anti-fibrotic effects

May 17, 2022

Recent data reinforce the anti-fibrotic activity of Aramchol previously observed in a wide range of pre-clinical models, in addition to the known effects in...

Hebrew University Allen Baharaff Aramchol Meglumine Galmed Pharmaceuticals Ltd Prnewswire Galmed Pharmaceuticals Ltd Open Label Part

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Armor Study News Today

Galmed Pharmaceuticals Reports First Quarter 2022 Financial Results

Galmed updates business and clinical development strategy to better leverage Aramchol's anti-fibrotic effects

Explore More Categories